SMi's 8th annual RNA Therapeutics conference will feature a mix of case study-led presentations, panel debates and interactive workshops tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems.
This exciting programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as: messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.
This exciting programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as: messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.
